Castle Biosciences Inc (CSTL)
29.81
+0.93
(+3.22%)
USD |
NASDAQ |
Nov 22, 16:00
29.81
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Shareholders Equity (Quarterly): 441.06M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 441.06M |
| June 30, 2024 | 423.89M |
| March 31, 2024 | 402.46M |
| December 31, 2023 | 391.27M |
| September 30, 2023 | 385.78M |
| June 30, 2023 | 378.77M |
| March 31, 2023 | 385.15M |
| December 31, 2022 | 399.15M |
| September 30, 2022 | 411.43M |
| June 30, 2022 | 421.66M |
| March 31, 2022 | 397.34M |
| December 31, 2021 | 411.74M |
| Date | Value |
|---|---|
| September 30, 2021 | 411.71M |
| June 30, 2021 | 415.92M |
| March 31, 2021 | 418.59M |
| December 31, 2020 | 415.69M |
| September 30, 2020 | 166.56M |
| June 30, 2020 | 157.62M |
| March 31, 2020 | 87.93M |
| December 31, 2019 | 85.11M |
| September 30, 2019 | 82.34M |
| June 30, 2019 | -3.594M |
| March 31, 2019 | 2.001M |
| December 31, 2018 | -10.07M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
85.11M
Minimum
Dec 2019
441.06M
Maximum
Sep 2024
350.44M
Average
400.81M
Median
Shareholders Equity (Quarterly) Benchmarks
| Delcath Systems Inc | 8.571M |
| Star Equity Holdings Inc | 58.37M |
| Exact Sciences Corp | 3.211B |
| CytoSorbents Corp | 13.00M |
| Progyny Inc | 434.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 514.56M |
| Total Liabilities (Quarterly) | 73.51M |
| Debt to Equity Ratio | 0.0227 |
| Current Ratio | 7.784 |
| Net Debt Paydown Yield | -0.25% |